Literature DB >> 8178224

Physical progress and residual impairment quantification after functional restoration. Part I: Lumbar mobility.

T Mayer1, J Tabor, E Bovasso, R J Gatchel.   

Abstract

Quantification of human performance in chronic low back pain (CLBP) patients is essential to initiate effective treatment and guide progress in a disability-oriented functional restoration program, as well as to objectively evaluate impairment and functional limitations at the time of maximum medical improvement. One such important measure of physical ability is range of motion. Patients who suffer from CLBP almost invariably have some disturbance of mobility. The major goals of the present study were to: 1) develop a database of anticipated range of motion levels at different points in time in a representative sample of CLBP patients; 2) within the sample, determine any gender or spinal surgery-induced differences; 3) evaluate change in range of motion produced by participation in a comprehensive functional restoration treatment program; and 4) identify residual impairment of regional range of motion. Four separate groups of CLBP patients were evaluated: Group 1 (n = 92), unoperated men; Group 2 (n = 26), postdiscectomy men; Group 3 (n = 59), unoperated women; and Group 4 (n = 17) postdiscectomy women. Patients in each group were assessed for spinal range of motion measures at three points in time, for sagittal/coronal motion and validity (employing the relationship between pelvic motion and supine leg raising). Results demonstrated dramatic patient improvements in range of motion from initial referral to program completion. The most significant gains were made in pelvic motion, which returned to near normal levels, indicating that the vast majority overcame low effort or movement inhibition produced by pain or fear of injury.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8178224

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  8 in total

Review 1.  Aggressive exercise as treatment for chronic low back pain.

Authors:  Isaac Cohen; James Rainville
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

2.  The pain disability questionnaire: relationship to one-year functional and psychosocial rehabilitation outcomes.

Authors:  Robert J Gatchel; Tom G Mayer; Brian R Theodore
Journal:  J Occup Rehabil       Date:  2006-03

3.  Correcting abnormal flexion-relaxation in chronic lumbar pain: responsiveness to a new biofeedback training protocol.

Authors:  Randy Neblett; Tom G Mayer; Emily Brede; Robert J Gatchel
Journal:  Clin J Pain       Date:  2010-06       Impact factor: 3.442

4.  The lack of association between changes in functional outcomes and work retention in a chronic disabling occupational spinal disorder population: implications for the minimum clinical important difference.

Authors:  Hilary D Wilson; Tom G Mayer; Robert J Gatchel
Journal:  Spine (Phila Pa 1976)       Date:  2011-03-15       Impact factor: 3.468

5.  Comparison of four physiotherapy regimens in the treatment of long-term mechanical low back pain.

Authors:  Olubusola E Johnson; Babatunde O A Adegoke; Samuel O Ogunlade
Journal:  J Jpn Phys Ther Assoc       Date:  2010

6.  What is the best surface EMG measure of lumbar flexion-relaxation for distinguishing chronic low back pain patients from pain-free controls?

Authors:  Randy Neblett; Emily Brede; Tom G Mayer; Robert J Gatchel
Journal:  Clin J Pain       Date:  2013-04       Impact factor: 3.442

7.  [Multidisciplinary treatment program for chronic low back pain, part 2. Somatic aspects].

Authors:  P Saur; J Hildebrandt; M Pfingsten; D Seeger; U Steinmetz; A Straub; J Hahn; B Kasi; R Heinemann; D Koch
Journal:  Schmerz       Date:  1996-10-28       Impact factor: 1.107

8.  Facilitating unequivocal and durable decisions in workers' compensation patients eligible for elective orthopedic surgery.

Authors:  Emily Brede; Tom G Mayer; Margareta Shea; Cristina Garcia; Robert J Gatchel
Journal:  J Pain       Date:  2013-10-02       Impact factor: 5.820

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.